Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Return on Invested Capital (2023 - 2026)

Axsome Therapeutics' Return on Invested Capital history spans 4 years, with the latest figure at 0.0% for Q1 2026.

  • On a quarterly basis, Return on Invested Capital rose 1.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 1.0% increase, with the full-year FY2025 number at 0.0%, up 1.0% from a year prior.
  • Return on Invested Capital hit 0.0% in Q1 2026 for Axsome Therapeutics, down from 0.0% in the prior quarter.
  • Over the last five years, Return on Invested Capital for AXSM hit a ceiling of 0.0% in Q4 2025 and a floor of 0.01% in Q4 2024.
  • Historically, Return on Invested Capital has averaged 0.01% across 4 years, with a median of 0.01% in 2024.
  • Biggest five-year swings in Return on Invested Capital: decreased -1bps in 2024 and later rose 1bps in 2025.
  • Tracing AXSM's Return on Invested Capital over 4 years: stood at 0.01% in 2023, then plummeted by -141bps to 0.01% in 2024, then surged by 86bps to 0.0% in 2025, then tumbled by -71bps to 0.0% in 2026.
  • Business Quant data shows Return on Invested Capital for AXSM at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.01% in Q3 2025.